Synonym develops biomanufacturing infrastructure and a dynamic database of contract manufacturers to facilitate the commercialization of next-generation bioproducts. By providing techno-economic analysis and lifecycle assessments, the company helps businesses scale production efficiently while addressing the challenges of supply chain sustainability and decarbonization.
Funding
$6.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Companies bringing next-generation bioproducts to market face challenges in scaling production due to a lack of suitable biomanufacturing infrastructure. They also struggle to efficiently plan and secure capacity with contract manufacturers (CMOs).
Solution
Synonym develops infrastructure for the bioeconomy, offering tools to help companies plan, match with CMOs, and develop dedicated production capacity. The company provides techno-economic analysis (TEA) and lifecycle assessment (LCA) for fermentation processes, enabling businesses to construct models and environmental analyses to inform their business strategies. Synonym also maintains a directory of contract manufacturers (CMOs) for fermentation, helping companies secure capacity and expand production. Furthermore, Synonym offers off-balance sheet development options in customized project finance structures to build turnkey, dedicated production capacity.
Target Audience
Synonym's primary customers are companies bringing next-generation bioproducts to market, particularly those in the plastics, alternative protein, and other bioeconomy sectors.
Features
- Scaler: Techno-economic analysis (TEA) and lifecycle assessment (LCA) for fermentation processes.
- Capacitor: Directory of contract manufacturers (CMOs) for fermentation.
- Turnkey, dedicated production capacity development with customized project finance structures.
- Support for planning, matching with CMOs, and developing dedicated production capacity.
- Collaboration with companies bringing next-generation bioproducts to market.